Chemomab Therapeutics Ltd. Adjustments For Increase Decrease In Employee Benefit Liabilities
Chemomab Therapeutics Ltd. (CMMB) reported Adjustments For Increase Decrease In Employee Benefit Liabilities of $526.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities · last filed 2019-04-24
| Period end | Adjustments For Increase Decrease In Employee Benefit Liabilities 12 month |
|---|---|
| 2018-12-31 | $526.00K 20-F · filed 2019-04-24 |
| 2017-12-31 | -$2.00K 20-F · filed 2019-04-24 |
| 2016-12-31 | -$60.00K 20-F · filed 2019-04-24 |